• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Cancer Therapeutics

Cancer Therapeutics

  1. Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase II Pancreatic Cancer Study

    Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase II Pancreatic Cancer Study

1
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.